ArticleInternational journal of cardiology2022
Characterization of cardiac amyloidosis using cardiac magnetic resonance fingerprinting.
Article in International journal of cardiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Promises and challenges of AI-enabled methods for myocardial characterisation in cardiovascular magnetic resonance.Frontiers in cardiovascular medicine · 2026Review
- Simultaneous free-breathing T1, T2, and T1ρ mapping for myocardial fibrosis detection in non-ischemic cardiomyopathy: A comparative study with conventional techniques.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2025Article
- Cardiac MR Fingerprinting: Overview, Technical Developments, and Applications.Journal of magnetic resonance imaging : JMRI · 2024Review
- Next-Generation Cardiac Magnetic Resonance Imaging Techniques for Characterization of Myocardial Disease.Current treatment options in cardiovascular medicine · 2024Article
- MR Fingerprinting for Contrast Agent-free and Quantitative Characterization of Focal Liver Lesions.Radiology. Imaging cancer · 2023Article
- Cardiac Magnetic Resonance Fingerprinting: Potential Clinical Applications.Current cardiology reports · 2023Review
- Fingerprinting MINOCA: Unraveling Clues With Quantitative CMR.JACC. Case reports · 2023Article
- Motion-compensated TFrontiers in cardiovascular medicine · 2023Review
- Simultaneous multi-parametric acquisition and reconstruction techniques in cardiac magnetic resonance imaging: Basic concepts and status of clinical development.Frontiers in cardiovascular medicine · 2022Review
- Quantitative MRI in cardiometabolic disease: From conventional cardiac and liver tissue mapping techniques to multi-parametric approaches.Frontiers in cardiovascular medicine · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundCardiac amyloidosis (CA) is an infiltrative cardiomyopathy with poor prognosis absent appropriate treatment. Elevated native myocardial T
methodsNine CA patients and five controls were scanned at 3 T using a prospectively gated cMRF acquisition. Two cMRF-based analysis approaches were examined: (1) relaxometric-based linear discriminant analysis (LDA) using native T
resultsElevated myocardial T
conclusionsThese findings suggest that cMRF may be a valuable technique for the detection and characterization of CA. Analysis of cMRF signal timecourse data may improve tissue characterization as compared to analysis of native T
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.